血液透析相关远端缺血的危险因素与管理
基于血管质量倡议血液透析通路登记(2011-2019)数据,35,236例通路建立中970例(2.75%)发生需干预的血液透析相关远端缺血(HADI)。多因素回归显示白人、女性、外周动脉疾病、冠心病、糖尿病、术后抗血小板、人工血管、上臂通路及目标静脉直径大于4毫米与HADI风险增加相关。HADI修复后12个月次级通畅率89.0% vs 无HADI 92.4%(P<0.01),但多因素Cox校正后HADI修复并非通路失败的独立显著相关因素。
要点
- HADI发生率为2.75%(970/35,236),中位发生时间49天(IQR 17-91天)。
- 白人女性伴糖尿病及动脉疾病、上臂人工血管通路者HADI风险更高。
- HADI修复后12个月次级通畅率89.0% vs 无HADI 92.4%(P<0.01),多因素校正后无独立显著关联。
核心结论
- HADI complicating 2.75% of hemodialysis access cases, more likely in white females with diabetes and arterial disease after upper arm prosthetic graft placement.
- The patency of dialysis access does not seem to be negatively impacted by the various methods of surgical revision for HADI.
研究设计与样本
- Review of the Vascular Quality Initiative hemodialysis access registry (2011-2019); 35,236 vascular access creations, 970 (2.75%) with HADI requiring intervention.
- Patients classified by occurrence of HADI requiring intervention; multivariable logistic regression for independent factors; Kaplan-Meier comparison of secondary patency after surgical revision modalities.
主要发现
- Treatment: access ligation 224 patients (23%), catheter-based techniques 394 (41%), banding 127 (13%), DRIL 196 (20%), PAI 15 (1.5%), RUDI 14 (1.4%).
- Median time to HADI 49 days (IQR 17-91 days).
- Multivariate regression: white race, female sex, peripheral artery disease, coronary artery disease, diabetes, post-procedure antiplatelets, prosthetic grafts, upper arm access, and target vein diameter greater than 4 mm were significantly associated with increased risk for HADI.
- Secondary patency at 12 months, HADI revision versus none: 89.0% vs 92.4%, P<0.01.
- After multivariate Cox adjustment, revision for HADI was not independently significantly associated with access failure.
关键数值与推荐
- HADI requiring intervention occurred in 970 of 35,236 access creations (2.75%).
- Median time to HADI 49 days (IQR 17-91 days).
- Secondary patency at 12 months, HADI revision versus none: 89.0% vs 92.4%, P<0.01.
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemodialysis-associated distal ischemia (HADI) is an uncommon, but significant complication after hemodialysis access creation that might require additional intervention. This study examines the risk factors for HADI and compares the outcomes of the different treatment modalities. METHODS: The Vascular Quality Initiative hemodialysis access (2011-2019) registry was reviewed. Patients were classified based on the occurrence of HADI requiring intervention or not, and their respective characteristics were compared. Multivariable logistic regression was used to identify independent factors associated with HADI. Kaplan Meier curves of secondary patency after different modalities of surgical revision were compared. RESULTS: There were 35,236 vascular access creations and 970 (2.75%) were complicated by HADI requiring intervention. Treatment was performed with access ligation in 224 patients (23%) and catheter-based techniques in 394 (41%). Open surgical revision consisted of banding in 127 (13%), distal revascularization interval ligation (DRIL) in 196 (20%), proximalization of arterial inflow (PAI) in 15 (1.5%), and revision using distal inflow (RUDI) in 14 (1.4%). Median time to HADI was 49 days (IQR 17 -91 days). Multivariate regression demonstrated that white race, female sex, peripheral artery disease, coronary artery disease, diabetes, post-procedure antiplatelets, prosthetic grafts, upper arm access, and target vein diameter greater than 4 mm were significantly associated with increased risk for HADI. When compared to procedures without HADI, access patency was decreased when revision (excluding access ligation) was performed (secondary patency at 12 months, HADI revision versus none: 89.0% vs. 92.4%, P <0.01). However, after multivariate Cox adjustment, revision for HADI was not independently significantly associated with access failure. CONCLUSION: HADI complicates 2.75% of hemodialysis access cases and is more likely in white females with diabetes and arterial disease after upper arm prosthetic graft placement. The patency of dialysis access does not seem to be negatively impacted by the various methods of surgical revision for HADI.
引用
- Lee SR, Dardik A, Siracuse J, et al. Risk Factors and Management of Hemodialysis Associated Distal Ischemia. Ann Vasc Surg. 2021. PMID: 34954373. doi:10.1016/j.avsg.2021.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。